The New York Times reported today that a little medical device company, Biotronik, with 5% market share in pacemakers and defibrillators, is Big Daddy in one certain medical center (some of whose doctors it hired) with 95% market share. And it got there in 3 years from 0% market share. Technically, that’s a growth rate of infinity. Many a firm is emboldened by 10%. This is a quick change of heart—devices. Plus clinical trial (all expenses paid).
Casualities in this story—at least 3:
- evidence-based medicine